Jack Huet

Structure−Activity Relationships in Platelet-Activating Factor (PAF). 10. From PAF Antagonism to Inhibition of HIV-1 Replication

Nawal Serradji, Okkacha Bensaid, Marc Martín et al. · Journal of Medicinal Chemistry · 2000 · 29 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Structural studies of metalloporphyrins. 7. Proton NMR and electrochemical investigation of the (meso-5,10,15,20-tetraarylporphine)cobalt(III) complexes XCoIII(TPP-p-R)

Jack Huet, A. Gaudemer, C. Boucly-Goester et al. · Inorganic Chemistry · 1982 · 28 citations

Natural Sciences, Biochemistry, Chemistry +10

Inhibition of secretory phospholipase A2. 2-Synthesis and structure–activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme

Chang‐Zhi Dong, Azali Ahamada‐Himidi, Stéphanie Plocki et al. · Bioorganic & Medicinal Chemistry · 2005 · 25 citations

Life Sciences, Biochemistry, Pharmacology +10

Inhibition of secretory phospholipase A. 1-Design, synthesis and structure–activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLAs

Leon Assogba, Azali Ahamada‐Himidi, Nadia Meddad-Bel Habich et al. · European Journal of Medicinal Chemistry · 2005 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Potentiometric, calorimetric and spectroscopic study of complexation between copper(II), nickel(II), and cobalt(II) and L,L-dipeptides containing weakly or non-co-ordinating side chains

Le Xiao, Mohamed Jouini, Baoyan Fan et al. · Journal of the Chemical Society Dalton Transactions · 1990 · 16 citations

Natural Sciences, Biochemistry, Chemistry +17